Treatment Landscape in HR+, HER2- MBC
ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial - Pharmacological Cardioprotective Strategy for Non-Metastatic Patients Affected by BC Receiving an Anthracycline-Based Chemo"
Login to view comments.
Click here to Login
Treatment Landscape in HR+, HER2- MBC